HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

Hepatitis B core-related antigen (HBcrAg) is a predictor of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients. Studies on anti-viral therapy have shown that the use of NUC therapy in HBV patients could reduce the incidence of HCC. However, the incidence of HCC continues to increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kuo-Chin, Lin, Ming-Tsung, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung, Chiu, Sherry Yueh-Hsia, Hu, Tsung-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782149/
https://www.ncbi.nlm.nih.gov/pubmed/36560675
http://dx.doi.org/10.3390/v14122671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782149/
https://www.ncbi.nlm.nih.gov/pubmed/36560675
http://dx.doi.org/10.3390/v14122671

Ejemplares similares